Globus医疗 GMED 深 沪
等待开盘 03-26 09:30:00 美东时间
87.35
+1.100
+1.28%
华盛通- 最 高87.7048
- 今 开86.63
- 成交量 71.75万股
- 最 低 85.42
- 昨 收 86.25
- 总市值 117.92亿
- 52周最高 101.3975
- 市盈率 静 22.26
- 换手率 0.53%
- 52周最低 51.79
- 委 比 -68.25%
- 总股本 1.35亿
- 历史最高 101.3975
- 量 比 0.70
- 振 幅 2.65%
- 历史最低 10.26
- 每 手 1
- 风险率 14.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多新浪财经ESG：Globus Medical Inc MSCI（明晟）ESG评级调降至CCC
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:21
Globus Medical Announces Board Resignation, Affirms Governance Stability
Globus Medical ( ($GMED) ) has issued an announcement. On March 23, 2026, Globu...
03-24 05:49
Globus Medical Announces Board Departure
John A. DeFord, PhD, has resigned from the Board of Directors of Globus Medical, Inc., effective immediately, and will not stand for re-election at the upcoming Annual Meeting of Stockholders. The company expressed gratitude for his contributions, especially during the merger with NuVasive and his work on the Nominating and Governance Committee. Dr. DeFord appreciated his time at Globus and the company’s growth as a leader in musculoskeletal tech...
03-23 21:25
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment
Royal Philips has announced proposed appointments and re-appointments to its Supervisory Board. John DeFord, an industry leader with extensive experience in medical devices, has been nominated as a new member. Paul Stoffels, Herna Verhagen, and Sanjay Poonen have been proposed for re-appointment due to their ongoing contributions and expertise. Marc Harrison will step down after completing his second term. Additionally, Roy Jakobs has been re-pro...
03-23 08:30
Portnoy Law Firm probes Globus Medical for potential securities fraud class action
Portnoy Law Firm probes Globus Medical for potential securities fraud class action Portnoy Law Firm said it has opened an investigation into possible securities fraud at Globus and may file a class action on behalf of investors. The firm linked the investigation to an FDA warning letter dated August
03-19 21:02
新浪财经ESG：Globus Medical Inc MSCI（明晟）ESG评级调降至B
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-14 07:00
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
Needham Maintains Buy on Globus Medical, Raises Price Target to $114
Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $112 to $114.
02-25 18:30
财报速睇 | Globus医疗 2025财年年度营收29.39亿美元，同比增长16.7%；归母净利润5.38亿美元，同比增长422.3%
华盛资讯2月25日讯，Globus医疗公布2025财年年度业绩，公司年度营收29.39亿美元，同比增长16.7%，归母净利润5.38亿美元，同比增长422.3%。
02-25 08:13
